FDA documents released in a Guidant defibrillator liability lawsuit indicate that failure rates may be considerably higher than the company has admitted. "This is as damaging a document as we're going to come across," said a plaintiff's attorney. Boston Scientific, Guidant's parent, estimates that 3,000 patients may plan to sue.

Related Summaries